Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Visco VisionTPE:6782 -0.56%87 Return-on-Tangible-Asset is 15.85% as of Mar. 2026, which is 4% above its 10-year median of 15.19. GuruFocus rates TPE:6782 with a GF Score™ of 87/100 and a GF Value™ of NT$330.93 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Visco Vision ranks better than 92.86% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Visco Vision's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$962 Mil. Visco Vision's average total tangible assets for the quarter that ended in Mar. 2026 was NT$6,070 Mil. Therefore, Visco Vision's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 15.85%.
The historical rank and industry rank for Visco Vision's Return-on-Tangible-Asset or its related term are showing as below:
TPE:6782'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.17 Med: 15.19 Max: 23.09
Current: 15.93
During the past 9 years, Visco Vision's highest Return-on-Tangible-Asset was 23.09%. The lowest was 6.17%. And the median was 15.19%.
TPE:6782's Return-on-Tangible-Asset is ranked better than 92.86% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.735
vs TPE:6782: 15.93
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Visco Vision Return-on-Tangible-Asset Related Terms
Visco Vision Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Visco Vision's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6782 vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, Visco Vision's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visco Vision Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visco Vision's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Visco Vision's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 15.85% mean?
Visco Vision (TPE:6782) has a Return-on-Tangible-Asset of 15.85% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Visco Vision and its competitors. This is near median its historical median of 15.19. Over the past decade, Visco Vision's Return-on-Tangible-Asset has ranged from 6.17 to 23.09. According to the industry distribution chart, Visco Vision ranks #61 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 7.1%.
Is Visco Vision's Return-on-Tangible-Asset too high?
Visco Vision's current Return-on-Tangible-Asset of 15.85% is near median its 10-year median of 15.19. Over the past 10 years, this metric has ranged from a low of 6.17 to a high of 23.09. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.74. Visco Vision's value of 15.85% is 2056.5% above this industry median. Based on the distribution chart, Visco Vision ranks #61 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Visco Vision has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Visco Vision's Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Visco Vision ranks #61 out of 854 companies for Return-on-Tangible-Asset. This places Visco Vision in the top 7% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.74. Visco Vision's value of 15.85% is 2056.5% above this benchmark. Historically, Visco Vision's own Return-on-Tangible-Asset has ranged from 6.17 to 23.09 over the past decade. While the company's 10-year median is 15.19 vs. the industry median of 0.74, Visco Vision has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.74, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Visco Vision's current Return-on-Tangible-Asset of 15.85% is 2056.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Visco Vision and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Visco Vision's current Return-on-Tangible-Asset is 15.85%, which is near median its own 10-year median of 15.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Visco Vision stock overvalued right now?
Based on GuruFocus' analysis, Visco Vision (TPE:6782) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$330.93, compared to a current price of NT$177.00 — trading 46.5% below its estimated fair value. The current Return-on-Tangible-Asset is 15.85%, which is near median its 10-year median of 15.19 and 2056.5% above the Medical Devices & Instruments industry median of 0.74. Visco Vision's overall GF Score™ is 87/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Visco Vision (TPE:6782), the current Return-on-Tangible-Asset is 15.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Visco Vision (TPE:6782) Overvalued in 2026?
Based on GuruFocus' analysis, Visco Vision stock appears to be undervalued.
The current stock price of NT$177.00 is trading 46.5% below its estimated GF Value™ of NT$330.93.
GuruFocus considers Visco Vision to be Significantly Undervalued.
Key valuation signals for TPE:6782:
Return-on-Tangible-Asset: 15.85% (near median its 10-year median of 15.19)
GF Value™: NT$330.93 vs. price of NT$177.00 (46.5% below fair value)
Industry Position: 2056.5% above the Medical Devices & Instruments median (#61 of 854)
No single metric tells the full story. See the TPE:6782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Visco Vision Inc is a manufacturer and seller of disposable contact lenses. The company manufactures Spherical Lenses, Multifocal lenses, Toric lenses, and Cosmetic lenses. Geographically, the company earns maximum revenue from Asia, followed by Europe, Taiwan, and the Americas.
87GF Score
Get the complete analysis for TPE:6782
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6782 has been successfully added to your 
